149 related articles for article (PubMed ID: 15208262)
21. Role of cellular adhesion molecules in HIV type 1 infection and their impact on virus neutralization.
Hioe CE; Bastiani L; Hildreth JE; Zolla-Pazner S
AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S247-54. PubMed ID: 9814951
[TBL] [Abstract][Full Text] [Related]
22. DC-SIGN points the way to a novel mechanism for HIV-1 transmission.
Masso M
MedGenMed; 2003 May; 5(2):2. PubMed ID: 14603101
[TBL] [Abstract][Full Text] [Related]
23. DC-SIGN, but not sDC-SIGN, can modulate IL-2 production from PMA- and anti-CD3-stimulated primary human CD4 T cells.
Martinez O; Brackenridge S; El-Idrissi Mel-A; Prabhakar BS
Int Immunol; 2005 Jun; 17(6):769-78. PubMed ID: 15944195
[TBL] [Abstract][Full Text] [Related]
24. Intercellular adhesion molecule-2 (ICAM-2) expression on human dendritic cells.
Hart DN; Prickett TC
Cell Immunol; 1993 May; 148(2):447-54. PubMed ID: 8098673
[TBL] [Abstract][Full Text] [Related]
25. Lactoferrin prevents dendritic cell-mediated human immunodeficiency virus type 1 transmission by blocking the DC-SIGN--gp120 interaction.
Groot F; Geijtenbeek TB; Sanders RW; Baldwin CE; Sanchez-Hernandez M; Floris R; van Kooyk Y; de Jong EC; Berkhout B
J Virol; 2005 Mar; 79(5):3009-15. PubMed ID: 15709021
[TBL] [Abstract][Full Text] [Related]
26. HLA-DR, ICAM-1, CD40, CD40L, and CD86 are incorporated to a similar degree into clinical human immunodeficiency virus type 1 variants expanded in natural reservoirs such as peripheral blood mononuclear cells and human lymphoid tissue cultured ex vivo.
Martin G; Tremblay MJ
Clin Immunol; 2004 Jun; 111(3):275-85. PubMed ID: 15183148
[TBL] [Abstract][Full Text] [Related]
27. Presence of host ICAM-1 in human immunodeficiency virus type 1 virions increases productive infection of CD4+ T lymphocytes by favoring cytosolic delivery of viral material.
Tardif MR; Tremblay MJ
J Virol; 2003 Nov; 77(22):12299-309. PubMed ID: 14581566
[TBL] [Abstract][Full Text] [Related]
28. Functional evaluation of DC-SIGN monoclonal antibodies reveals DC-SIGN interactions with ICAM-3 do not promote human immunodeficiency virus type 1 transmission.
Wu L; Martin TD; Vazeux R; Unutmaz D; KewalRamani VN
J Virol; 2002 Jun; 76(12):5905-14. PubMed ID: 12021323
[TBL] [Abstract][Full Text] [Related]
29. Statin compounds reduce human immunodeficiency virus type 1 replication by preventing the interaction between virion-associated host intercellular adhesion molecule 1 and its natural cell surface ligand LFA-1.
Giguère JF; Tremblay MJ
J Virol; 2004 Nov; 78(21):12062-5. PubMed ID: 15479847
[TBL] [Abstract][Full Text] [Related]
30. Human hepatoma cells transmit surface bound HIV-1 to CD4+ T cells through an ICAM-1/LFA-1-dependent mechanism.
Fromentin R; Tardif MR; Tremblay MJ
Virology; 2010 Mar; 398(2):168-75. PubMed ID: 20034651
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C virus targets DC-SIGN and L-SIGN to escape lysosomal degradation.
Ludwig IS; Lekkerkerker AN; Depla E; Bosman F; Musters RJ; Depraetere S; van Kooyk Y; Geijtenbeek TB
J Virol; 2004 Aug; 78(15):8322-32. PubMed ID: 15254204
[TBL] [Abstract][Full Text] [Related]
32. LFA-1 is a key determinant for preferential infection of memory CD4+ T cells by human immunodeficiency virus type 1.
Tardif MR; Tremblay MJ
J Virol; 2005 Nov; 79(21):13714-24. PubMed ID: 16227291
[TBL] [Abstract][Full Text] [Related]
33. DC-SIGN: binding receptors for hepatitis C virus.
Wang QC; Feng ZH; Nie QH; Zhou YX
Chin Med J (Engl); 2004 Sep; 117(9):1395-400. PubMed ID: 15377434
[TBL] [Abstract][Full Text] [Related]
34. The amount of host HLA-DR proteins acquired by HIV-1 is virus strain- and cell type-specific.
Cantin R; Fortin JF; Tremblay M
Virology; 1996 Apr; 218(2):372-81. PubMed ID: 8610464
[TBL] [Abstract][Full Text] [Related]
35. DC-SIGN (dendritic cell-specific ICAM-grabbing non-integrin) and DC-SIGN-related (DC-SIGNR): friend or foe?
Soilleux EJ
Clin Sci (Lond); 2003 Apr; 104(4):437-46. PubMed ID: 12653690
[TBL] [Abstract][Full Text] [Related]
36. Remote T cell co-stimulation via LFA-1/ICAM-1 and CD2/LFA-3: demonstration with immobilized ligand/mAb and implication in monocyte-mediated co-stimulation.
Van Seventer GA; Shimizu Y; Horgan KJ; Luce GE; Webb D; Shaw S
Eur J Immunol; 1991 Jul; 21(7):1711-8. PubMed ID: 1711977
[TBL] [Abstract][Full Text] [Related]
37. Presence of host ICAM-1 in laboratory and clinical strains of human immunodeficiency virus type 1 increases virus infectivity and CD4(+)-T-cell depletion in human lymphoid tissue, a major site of replication in vivo.
Bounou S; Leclerc JE; Tremblay MJ
J Virol; 2002 Feb; 76(3):1004-14. PubMed ID: 11773376
[TBL] [Abstract][Full Text] [Related]
38. Susceptibility of HIV type 1 to the fusion inhibitor T-20 is reduced on insertion of host intercellular adhesion molecule 1 in the virus membrane.
Beauséjour Y; Tremblay MJ
J Infect Dis; 2004 Sep; 190(5):894-902. PubMed ID: 15295693
[TBL] [Abstract][Full Text] [Related]
39. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses.
Geijtenbeek TB; Torensma R; van Vliet SJ; van Duijnhoven GC; Adema GJ; van Kooyk Y; Figdor CG
Cell; 2000 Mar; 100(5):575-85. PubMed ID: 10721994
[TBL] [Abstract][Full Text] [Related]
40. Intercellular adhesion molecule 1 (ICAM-1), but not ICAM-2 and -3, is important for dendritic cell-mediated human immunodeficiency virus type 1 transmission.
Wang JH; Kwas C; Wu L
J Virol; 2009 May; 83(9):4195-204. PubMed ID: 19211748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
